Quantcast

Latest Guidant Corp. Stories

2006-06-07 07:29:34

NEW YORK (Reuters) - Newly released records show that Guidant Corp. drafted a letter last year to tell doctors about significant defects in the company's heart devices, but they were never sent, a report said on Wednesday. Heart patients apparently kept getting the devices, advanced defibrillators known as Contak Renewal and Contak Renewal 2, which Guidant said in the proposed letter had electrical flaws, The New York Times said. The "dear doctor" letter dated January 2005 also told...

2006-05-15 13:29:23

By Susan Kelly CHICAGO (Reuters) - Boston Scientific Corp. on Monday said it had notified doctors that some of its implantable cardiac devices, which it acquired as part of its purchase of Guidant Corp. last month, could be at risk for early battery depletion. Boston Scientific, whose shares fell 1 percent, said the problem occurred in a single lot of 996 implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillator devices that had been implanted in...

2006-05-15 12:12:22

By Susan Kelly CHICAGO (Reuters) - Boston Scientific Corp. on Monday said it had notified doctors that some of its implantable cardiac devices, which it acquired as part of its purchase of Guidant Corp. last month, could be at risk for early battery depletion. Boston Scientific, whose shares fell 1 percent, said the problem occurred in a single lot of 996 implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillator devices that had been implanted in...

2006-03-21 16:25:09

CHICAGO (Reuters) - Cardiovascular device maker Guidant Corp. said on Tuesday an outside panel it commissioned found its methods for reporting flaws in its devices consistently failed to consider patient safety. Guidant, which has been plagued by product recalls and is being acquired by Boston Scientific Corp., said the panel recommended that it develop processes to identify and act on even a single device malfunction when it is associated with the risk of death or serious injury....

2006-03-14 09:07:41

By Lisa Richwine ATLANTA (Reuters) - Patients with implanted heart devices that were subject to U.S. recalls or safety warnings do not have higher death rates than those who had devices that were not linked to such problems, a study released on Monday said. Guidant Corp. and other manufacturers have issued a series of recalls over the past few years for implanted cardioverter defibrillators (ICDs) and pacemakers. Some of the recalls warned of serious problems such as device...

2006-03-13 09:27:18

CHICAGO (Reuters) - Guidant Corp., the heart device maker that has been plagued by a series of product recalls, on Monday said it is voluntarily notifying physicians of battery problems in some Contak Renewal 3 RF and Renewal 4 RF implantable cardiac defibrillators. Guidant said it has received 39 reports of lower-than-expected battery voltage in the heart rhythm management devices prior to implant, and that none of those products were implanted. Of the approximately 4,000 Renewal 3...

2006-01-23 12:25:49

CHICAGO (Reuters) - Guidant Corp., the object of a bidding war between Johnson & Johnson and Boston Scientific Corp., on Monday said it has identified another batch of older-model pacemakers that are at risk of malfunction. Guidant said the U.S. Food and Drug Administration has told the company it may consider the information an expansion of the original Class I recall on the pacemaker models. The device maker recommended physicians reassess their patients due to the discovery of...

2006-01-23 12:25:00

CHICAGO (Reuters) - Guidant Corp., the object of a bidding war between Johnson & Johnson and Boston Scientific Corp., on Monday said it has identified another batch of older-model pacemakers that are at risk of malfunction. Guidant said the U.S. Food and Drug Administration has told the company it may consider the information an expansion of the original Class I recall on the pacemaker models. The device maker recommended physicians reassess their patients due to the discovery of...

2006-01-19 11:22:59

CHICAGO (Reuters) - The New York Times is scheduled to appear in a Texas courtroom on Thursday to request the release of documents that may show medical device maker Guidant Corp. knew its implantable heart defibrillators had a potentially fatal flaw before selling them, according to a plaintiffs' attorney. Guidant, the subject of a heated bidding war between Johnson & Johnson and Boston Scientific Corp., faces product liability lawsuits related to its July 2005 recall of...

2006-01-08 19:05:00

By Debra Sherman and Jessica Hall CHICAGO/PHILADELPHIA -- Boston Scientific Corp. on Sunday formalized its $25 billion cash and stock offer to acquire Guidant Corp. in a move to woo the medical-device maker away from its existing merger partner, Johnson & Johnson. The purchase of Guidant would give Boston Scientific access to the $10 billion market for pacemakers and defibrillators, devices that help regulate heart beats and the main drivers in J&J's bid for Guidant. The price of...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related